Literature DB >> 19262523

rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.

Jürgen Glas1, Julia Seiderer, Giulia Pasciuto, Cornelia Tillack, Julia Diegelmann, Simone Pfennig, Astrid Konrad, Silke Schmechel, Martin Wetzke, Helga-Paula Török, Johannes Stallhofer, Matthias Jürgens, Thomas Griga, Wolfram Klein, Jörg T Epplen, Uwe Schiemann, Thomas Mussack, Peter Lohse, Burkhard Göke, Thomas Ochsenkühn, Matthias Folwaczny, Bertram Müller-Myhsok, Stephan Brand.   

Abstract

OBJECTIVES: Recently, a North American genome-wide association study identified three novel gene variants in PHOX2B, NCF4, and FAM92B as well as one single nucleotide polymorphisms (SNP; rs224136) in the intergenic region on chromosome 10q21.1 as being associated with Crohn's disease (CD). However, their influence on European CD patients as well as ulcerative colitis (UC) is unknown. Therefore we aimed to replicate these novel CD susceptibility variants in a large European cohort with inflammatory bowel disease and analyzed potential gene-gene interactions with variants in the NOD2/CARD15, IL23R, and ATG16L1 genes.
METHODS: Genomic DNA from 2,833 Caucasian individuals including 854 patients with CD, 476 patients with UC, and 1,503 healthy unrelated controls was analyzed for SNPs in PHOX2B (rs16853571), NCF4 (rs4821544), and FAM92B (rs8050910), including rs224136 on chromosome 10q21.1.
RESULTS: In our study population, no association of PHOX2B (P=0.563), NCF4 (P=0.506), FAM92B (P=0.401), and rs224136 (P=0.363) with CD was found. Similarly, none of these SNPs was associated with UC. In contrast, all analyzed SNPs in NOD2/CARD15, IL23R, and ATG16L1 were strongly associated with CD with P values ranging from 5.0x10(-3) to 1.6x10(-22), but there was no epistasis with polymorphisms in PHOX2B, NCF4, FAM92B, and rs224136.
CONCLUSIONS: In contrast to the North American population, PHOX2B, NCF4, FAM92B, and rs224136 are not associated with CD in the European population, whereas NOD2/CARD15, IL23R, and ATG16L1 are strongly associated with CD in both the North American and European populations, confirming these three genes as major CD susceptibility genes in Caucasian populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19262523     DOI: 10.1038/ajg.2008.65

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

Review 1.  Association between NCF4 rs4821544T/C polymorphism and inflammatory bowel disease risk in Caucasian: a meta-analysis.

Authors:  Peng-Bo Wu; Jin-Fen Dai; Qian Wang; Guo Zhang; Shi-Yun Tan; Ming Li; Hui-Lan Ye
Journal:  Inflamm Res       Date:  2015-08-20       Impact factor: 4.575

2.  T300A polymorphism of ATG16L1 and susceptibility to inflammatory bowel diseases: a meta-analysis.

Authors:  Jia-Fei Cheng; Yue-Ji Ning; Wei Zhang; Zong-Hai Lu; Lin Lin
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

3.  Variants in ZNF365 isoform D are associated with Crohn's disease.

Authors:  Talin Haritunians; Michelle R Jones; Dermot P B McGovern; David Q Shih; Robert J Barrett; Carrie Derkowski; Marla C Dubinsky; Debra Dutridge; Phillip R Fleshner; Andrew Ippoliti; Lily King; Esther Leshinsky-Silver; Arie Levine; Gil Y Melmed; Emebet Mengesha; Eric A Vasilauskas; Shabnam Ziaee; Jerome I Rotter; Stephan R Targan; Kent D Taylor
Journal:  Gut       Date:  2011-01-21       Impact factor: 23.059

4.  Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas.

Authors:  John P Lee; Yin P Hung; Thomas M O'Dorisio; James R Howe; Jason L Hornick; Andrew M Bellizzi
Journal:  Histopathology       Date:  2017-07-13       Impact factor: 5.087

5.  The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.

Authors:  Martin Storr; Dominik Emmerdinger; Julia Diegelmann; Simone Pfennig; Thomas Ochsenkühn; Burkhard Göke; Peter Lohse; Stephan Brand
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

6.  NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2.

Authors:  Aleixo M Muise; Wei Xu; Cong-Hui Guo; Thomas D Walters; Victorien M Wolters; Ramzi Fattouh; Grace Y Lam; Pingzhao Hu; Ryan Murchie; Mary Sherlock; Juan Cristóbal Gana; Richard K Russell; Michael Glogauer; Richard H Duerr; Judy H Cho; Charlie W Lees; Jack Satsangi; David C Wilson; Andrew D Paterson; Anne M Griffiths; Mark S Silverberg; John H Brumell
Journal:  Gut       Date:  2011-09-07       Impact factor: 23.059

7.  CEACAM6 gene variants in inflammatory bowel disease.

Authors:  Jürgen Glas; Julia Seiderer; Christoph Fries; Cornelia Tillack; Simone Pfennig; Maria Weidinger; Florian Beigel; Torsten Olszak; Ulrich Lass; Burkhard Göke; Thomas Ochsenkühn; Christiane Wolf; Peter Lohse; Bertram Müller-Myhsok; Julia Diegelmann; Darina Czamara; Stephan Brand
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

8.  PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sites.

Authors:  Jürgen Glas; Julia Seiderer; Darina Czamara; Giulia Pasciuto; Julia Diegelmann; Martin Wetzke; Torsten Olszak; Christiane Wolf; Bertram Müller-Myhsok; Tobias Balschun; Jean-Paul Achkar; M Ilyas Kamboh; Andre Franke; Richard H Duerr; Stephan Brand
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

9.  IRGM variants and susceptibility to inflammatory bowel disease in the German population.

Authors:  Jürgen Glas; Julia Seiderer; Stephanie Bues; Johannes Stallhofer; Christoph Fries; Torsten Olszak; Eleni Tsekeri; Martin Wetzke; Florian Beigel; Christian Steib; Matthias Friedrich; Burkhard Göke; Julia Diegelmann; Darina Czamara; Stephan Brand
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

Review 10.  Genetic disorders coupled to ROS deficiency.

Authors:  Sharon O'Neill; Julie Brault; Marie-Jose Stasia; Ulla G Knaus
Journal:  Redox Biol       Date:  2015-07-17       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.